Moderna, Pfizer To Study Effects of mRNA Vaccines on Heart Health
(TheRedWire.com) – The Food and Drug Administration (FDA) approved Pfizer’s COVID-19 vaccine under an Emergency Use Authorization (EUA) on December 11, 2020. A week later, it did the same for Moderna. According to the FDA, it grants an EUA when the federal agency hasn’t yet approved a medical product, but it’s needed to treat a life-threatening disease in the absence of an available alternative. Now, almost two years later, the two pharmaceutical giants are studying the possible effects of the mRNA vaccines on heart health.
Pfizer is partnering with the Pediatric Heart Network to learn about its vaccine’s health risks. The study will focus on individuals who experienced heart issues that developed after they received a vaccine dosage. Moderna is also looking into possible side effects of their vaccine.
"Now, nearly two years later, Pfizer and Moderna will launch clinical trials to track adverse health issues stemming from the COVID-19 vaccines…"https://t.co/InRRS98u1z
— TheBlaze (@theblaze) November 15, 2022
Moderna Chief Medical Officer, Dr. Paul Burton, told NBC News scientists aren’t sure what caused the issues. He suggested that spike proteins might stimulate an adverse reaction causing heart inflammation.
In July 2021, the Centers for Disease Control (CDC) reported that males 12 to 29 years old faced an elevated risk of myocarditis if they received an mRNA COVID vaccine. In a separate report, the health agency said myocarditis and pericarditis were rare, but some cases presented among adolescents and young adults within days of vaccination.
A separate Israeli study found neither heart issue was present in adult patients who recovered from COVID-19.
Copyright 2022, TheRedWire.com